China Cord Blood Corporation Announces Participation in Upcoming Investor Conferences

HONG KONG, Sept. 6, 2011 /PRNewswire-Asia/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will participate in the following investor conferences:

• The Morgan Stanley Global Healthcare Conference, to be held September 13-14, 2011 at the Grand Hyatt New York, and the Morgan Stanley China Healthcare Day, to be held September 15, 2011 at the Four Seasons Hotel in Boston.  Management is scheduled to present and to meet with institutional investors throughout both days of both conferences.

• The UBS Global Life Sciences Conference, to be held September 19-21, 2011 at the Grand Hyatt New York.  Management is scheduled to present and to meet with institutional investors throughout the first two days of the conference.

For further details, please contact your respective institutional sales representatives.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today.  China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com .  

For more information, please contact:

China Cord Blood Corporation
Ms. Joeling Law
Tel:     +852-3605-8180
Email: ir@chinacordbloodcorp.com  

ICR, Inc.
In New York:
Ashley Ammon De Simone
Tel: +1-646-277-1227

In Beijing:
Wen Lei Zheng
Tel: +86-10-6583-7510